Western Australia doctors are investigating a procedure they claim can reduce the risk of developing the rare disease.
The researchers have used a technique called an endometriaplasty that uses a small amount of tissue from the inside of the lining of the uterus to deliver a gel from a tiny needle.
The gel is injected into the endometrium of a woman’s fallopian tube.
It can also be used on an ovary.
The gel could be used to treat endometritis in women with endometrhoea, which is the inflammation of the end of the ovary or fallopian tubes.
“The procedure is an option for those women who have symptoms of endometrically abnormal bleeding, and the treatment is potentially life-saving for those patients,” Dr Kate Taylor, a professor of endocrinology and fertility at the University of Western Australia, said.
“The treatment has been around for more than a decade and there’s no evidence that it’s been shown to be effective.”
It’s a procedure that’s been used for about 15 years in Australia, but there’s been little clinical trial data to show it’s a good treatment for endosyndromes in women.
Dr Taylor said it could be useful in women who had had the condition before the treatment, but that there were no specific studies looking at whether it would work for them.
“We need more data to make sure that it works for the majority of women,” she said.
“That’s why we’re doing this study, to find out whether it works as well for the vast majority of endosymptomatic women, and whether it’s really safe.”
Dr Taylor’s team said their technique was based on a new technique called intra-abdominal ultrasound, which can be performed without a doctor present.
“What’s happening here is that the gel is being inserted through the uterus in the uterus, and it then moves up to the ovaries, which are inside the uterus,” Dr Taylor said.
The ultrasound scan is then taken to check whether there are any abnormal structures in the endocervical and pelvic canal that could be causing pain.
“It’s basically measuring the size of the space around the endosynovacervical (ovary) and pelvic junction, which tells us whether the endo is functioning,” Dr Tayler said.
This scan can show if there are endometroses, or abnormal cells that form inside the endocrine system.
If there are no abnormal structures, the gel can then be injected into a woman.
A woman would then be placed on a waiting list to receive a treatment, which would usually last about six weeks.
The procedure was originally developed in the US, but was then shown to have benefits in the Western Australian study.
Dr Taylor and her team have also published their results in the journal Endocrinology.
Topics:arts-and-entertainment,women,health,women-health,endometriasis,endothelioma-endothelial-dissection,cancer,medical-research,australia,washington-dc,united-states,auFirst posted April 02, 2020 13:03:08Contact the ABC’s health team